載入...
Pharmacokinetics and Imaging of (212)Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients
Purpose: Study distribution, pharmacokinetics, and safety of intraperitoneal (IP) (212)Pb-TCMC-trastuzumab in patients with HER-2-expressing malignancy. Experimental Design: IP (212)Pb-TCMC-trastuzumab was delivered, after 4 mg/kg intravenous (IV) trastuzumab, to 3 patients with HER-2-expressing can...
Na minha lista:
Main Authors: | , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Mary Ann Liebert, Inc.
2014
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3869429/ https://ncbi.nlm.nih.gov/pubmed/24229395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cbr.2013.1531 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|